Caffeine intake in adults with cardiovascular diseases; A cross-sectional study

Basit Öğe Kaydı
dc.authoridBozkır, Çiğdem/0000-0002-1103-6290
dc.authoridTuggum, Sergen/0000-0002-0519-7039
dc.authorwosidBozkır, Çiğdem/ABA-6429-2020
dc.contributor.authorBozkir, Cigdem
dc.contributor.authorTuggum, Sergen
dc.contributor.authorKagan, Nursena
dc.contributor.authorNizam, Beydanur
dc.contributor.authorAlpsoy, Seref
dc.date.accessioned2024-08-04T20:52:07Z
dc.date.available2024-08-04T20:52:07Z
dc.date.issued2024
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: Caffeine in the safe dose range has been associated with a reduction in the risk of chronic diseases. There is evidence that caffeine intake has both protective and negative effects on cardiovascular diseases. Aim: This study aimed to investigate caffeine intake in cardiovascular patients. Methods: The study sample was selected from individuals who applied to the Cardiology policlinic of Tekirdag Namik Kemal University Hospital. A questionnaire was applied using face-to-face interview method to determine their demographic information, nutritional status and anthropometric measurements. Moreover, the nutritional status of the participants was determined by the Food Frequency Questionnaire and the type of cardiovascular disease was determined by a physician. The blood parameters of the sample for the last three months were questioned. The sample has been ninety people of whom fifty cardiovascular diseases (CVDs) were diagnosed and forty were non-diagnosed (ND). Results: The mean age of individuals (n = 90) was 43.2 +/- 14.4. The BMI and waist circumference of the CVDs group were statistically significantly higher than the ND group (p < 0.001). While the total caffeine consumption of the ND group was 209.34 +/- 143.85 mg/day, consumption of the CVDs group was 209.99 +/- 196.76 mg/day. LDL cholesterol and total cholesterol did not show statistically significant difference between the two groups. However, HDL cholesterol was significantly higher in the ND group (p <= 0.001). Conclusion: Present results show that daily caffeine consumption may partially affect blood parameters associated with cardiovascular diseases, especially in the presence of coronary artery disease.en_US
dc.identifier.doi10.1177/02601060221105030
dc.identifier.endpage148en_US
dc.identifier.issn0260-1060
dc.identifier.issn2047-945X
dc.identifier.issue1en_US
dc.identifier.pmid35763489en_US
dc.identifier.scopus2-s2.0-85133388457en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage139en_US
dc.identifier.urihttps://doi.org/10.1177/02601060221105030
dc.identifier.urihttps://hdl.handle.net/11616/100765
dc.identifier.volume30en_US
dc.identifier.wosWOS:000818505300001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofNutrition and Healthen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCaffeineen_US
dc.subjectcardiovascular diseasesen_US
dc.subjectfood consumptionen_US
dc.subjectcoffeeen_US
dc.subjectcoffee consumptionen_US
dc.titleCaffeine intake in adults with cardiovascular diseases; A cross-sectional studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu